Evidence map›Paper›PMID 32343839›Full record

Observational studyThe British journal of dermatology2020

The impact of the COVID-19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: the Northern Italy experience.

P Gisondi, P Facheris, P Dapavo, S Piaserico, A Conti, L Naldi, S Cazzaniga, P Malagoli, A Costanzo

Abstract readLetterMulticenter StudyObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in The British journal of dermatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Guideline
  5. Pooled it
  6. Pooled it
  7. Guideline
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Inflammation Causes Exacerbation of COVID-19: How about Skin Inflammation?International journal of molecular sciences · 2022
    Review
  18. Review
  19. Review
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

P GisondiDepartment of Medicine, Section of Dermatology and Venereology, University of Verona, Italy.ORCID 0000-0002-1777-9001
P FacherisDermatology Unit, Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
P DapavoDepartment of Biomedical Science and Human Oncology, Second Dermatologic Clinic, University of Turin, Turin, Italy.
S PiasericoSection of Dermatology, Department of Medicine, University of Padua, Padova, Italy.
A ContiDepartment of Surgical, Medical, Dental and Morphological Sciences related to Transplant, Oncology and Regenerative Medicine, Dermatology Unit, University of Modena and Reggio Emilia, Modena, Italy.ORCID 0000-0003-4848-3817
L NaldiDepartment of Dermatology, San Bortolo Hospital, Vicenza, Italy.
S CazzanigaCentro Studi GISED, Bergamo, Italy.ORCID 0000-0001-8161-6138
P MalagoliDermatology Unit, Azienda Ospedaliera San Donato Milanese, Milan, Italy.
A CostanzoDermatology Unit, Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedBetacoronavirusBiological ProductsComorbidityCoronavirus InfectionsCOVID-19FemaleHospitalizationHospital MortalityHumansItalyMaleMiddle AgedPandemicsPneumonia, ViralBiological Products

Identifiers

PMID32343839
PMCPMC7267283

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.